Stock Analysts

Alcatel-Lucent to Aid TIM’s Network Modernization Plans

Alcatel-Lucent ALU is all set to deploy its portfolio of IP core routing and Carrier software-defined networking technology to help Italy-based operator Telecom Italia’s TIM optimize its cloud services. TIM is undergoing a major transformation to create “Next Generation Core Network” in order to support greater service agility. To support TIM’s network modernization, Alcatel-Lucent is providing 7950 Extensible Routing System (XRS) IP Core Router portfolio, 1830 Photonic Service Switch to enable 100G agile optical networking technology, 5620 Service Aware Manager and SDN-based Network Services Platform […]

Stock Analysts

PPG JV Launches Automotive Refinish Paint in Sri Lanka

PPG Asian Paints, a joint venture between PPG Industries, Inc. PPG and India's Asian Paints, recently launched Envirobase High Performance (“HP”) automotive refinish paints in Sri Lanka. This is the first eco-friendly waterborne automotive paint line introduced in Sri Lanka for the refinishing industry. […]

Stock Analysts

Halozyme Inks Collaboration Deal with Eli Lilly for Enhanze

Halozyme Therapeutics, Inc. HALO announced that it has entered into a global collaboration and license agreement with Eli Lilly and Company LLY for the development and commercialization of therapies that will combine the latter’s compounds with Halozyme's Enhanze platform. Terms of the Deal Per the terms of the agreement, Eli Lilly will pay Halozyme an initial payment of $25 million […]

Stock Analysts

Baxalta’s Adynovate Positive in Phase III Pediatric Study

Baxalta Incorporated BXLT announced initial top-line data from an uncontrolled, open-label, multi-center phase III study on its hemophilia A drug, Adynovate. The study was conducted to evaluate the safety and immunogenicity of Adynovate and enrolled 73 previously treated patients (PTPs) with severe hemophilia A younger than 12 years of age and assessed the treatment’s hemostatic efficacy in prophylaxis and treatment of bleeding episodes. Results showed that no patient developed inhibitory antibodies to Adynovate, thereby meeting the primary endpoint of the study. […]

Stock Analysts

Repros Provides Update on Proellex Program, Data by 3Q16

Repros Therapeutics Inc. RPRX announced that it expects that top-line data from all three of the ongoing studies on Proellex can be reported by the end of the third quarter of 2016. While each of the three placebo controlled, double-blind studies has enrolled or will enroll about 45 patients, each study has a placebo arm and two drug arms – 6 and 12 mg of Proellex […]

Stock Analysts

Retail Properties of America Secures $1.2B Credit Facility

Retail Properties of America, Inc. RPAI has secured an amended and restated unsecured credit facility worth $1.2 billion. This development not only expands the Oak Brook, IL-based retail real estate investment trust’s total capacity by $200 million, but also indicates its ability to raise funds from the unsecured debt market […]